Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Melanoma Research Alliance commits strategic research funding to improve the understanding about the causes of melanoma and to develop better treatments for this deadly disease.
A conversation with Dr. Alexandra-Chloé Villani about side effects experienced by melanoma patients undergoing immunotherapy
This report highlights the estimated number of new cases, prevalence, and survival statistics for cancer in the United States.
We all have trillions of microorganisms that live throughout our bodies.
Lack of awareness of and participation in clinical trials are the biggest obstacles to bringing new skin cancer therapies to market.
In the bustling holiday season, finding peace can be a gift.
When his skin cancer returned, Clay Hummer sought clinical trials for more options to treatment the melanoma.
Research is conﬁrming that artiﬁcial intelligence and machine learning algorithms may revolutionize the speed of melanoma diagnosis.
Watch MRA CEO Dr. Marc Hurlbert and Army Veteran Andrew Smith discuss the risk of this skin cancer among the military and veterans.
Roughly nine out of ten skin cancers— including melanoma—are caused by unprotected exposure to UV rays.
Adjuvant immunotherapy can help reduce the likelihood of the skin cancer returning, but is more better or is less more?
Reducing the risk of this deadly skin cancer recurring after surgery is an important goal, notes the Melanoma Research Alliance.
Melanoma Research Alliance interviews Dr. Hussein Tawbi, who led a clinical trial on the immunotherapy drug Opdualag.
Melanoma skin cancer cells may spread, or metastasize, in the brain and cerebrospinal ﬂuid. Here’s a roundtable discussion on the topic.
Surgery for this rare cancer required the removal of Walther’s left eye. “This is my journey,” she said, “and I have to travel it.”
The Melanoma Research Alliance’s Patient Advocate Scientific Retreat and Patient Forum take place in DC during February 2024.
“Today’s action reminds patients facing rare melanoma that they aren’t being left behind,” one expert said.
When cancer treatment made her feel uncomfortable in everyday clothing, Paloma Soledad founded Krysalis Kouture.
Jamie Goldfarb and Ken Billett, both melanoma survivors, share how their lives have been shaped by recent advances in melanoma research.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.